Periodic Reporting for period 1 - SMD-SPH (Development of scalable microfluidic device for drug testing using humanized adipose tissue spheroids)

In regenerative medicine, advanced therapeutic products derived from tissue engineering technologies and are critical for more accurate medical innovation. Tissue engineered scaffold-free 3D models, including organoids, exhibit functional hallmarks of human native tissues...